Thousands of lives—and potentially billions of dollars—are at stake in approval by the FDA of dueling drugs from Sarepta and BioMarin.
Thousands of lives—and potentially billions of dollars—are at stake in approval by the FDA of dueling drugs from Sarepta and BioMarin.